Diversion-p64 Post Market Clinical Follow-Up Study to Assess Safety and Effectiveness of the p64 Flow Modulation Device

Clinical trial NCT02600364 · COMPLETED

Trial details

NCT number: NCT02600364
Sponsor: Phenox GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Intracranial Aneurysm

Start date: 2015-12-01
Primary completion: 2020-06-01
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.